New Bladder-Saving cancer treatment trial seeks participants
NCT ID NCT07279597
Summary
This study is testing whether a combination of targeted drugs (toripalimab and RC48-ADC) plus radiation can effectively treat muscle-invasive bladder cancer while allowing patients to keep their bladder. The trial will enroll 45 adults with HER2-positive bladder cancer who have already had initial surgery and chemotherapy. Participants will receive the drug combination alongside radiation, followed by maintenance therapy for those who respond well.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.